One of the losers of today's trading session was PDD. Shares of the Business services company plunged -3.1%, and some ...

TG Therapeutics's revenues have an average growth rate of 333.9% with operating expenses growing at -6.5%. The company's ...

Short selling involves borrowing shares and then selling them at current market prices. In the successful version of the ...

In the 10-Q report, the company's Management's Discussion and Analysis of Financial Condition and Results of Operations ...

One of the losers of today's trading session was Altria. Shares of the Tobacco company plunged -4.0%, and some investors may be wondering if its price of $56.44 would make a good entry point. Here's ...

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) has announced the pricing of its underwritten offering of $200 million, with each share priced at $9,935,419. The company anticipates gross proceeds of ...

Genmab A/S trades -39.94% away from its average analyst target price of $31.0 per share. The 8 analysts following the stock ...

Thermo Fisher Scientific trades -26.76% away from its average analyst target price of $659.08 per share. The 28 analysts ...

BKR has a forward P/E ratio of 17.3 based on its forward 12 month price to earnings (EPS) of $2.57 per share Its Price to ...

These figures are in line with Rivian's previously stated outlook, where the company had projected production of ...

This divestiture is part of Leggett & Platt's ongoing strategic business review to determine the right long-term fit for the ...

In its 10-K report, nCino disclosed its financial condition and results of operations for fiscal 2025 and 2024. The company ...